Assay and Drug Development Technologies · 2012 · 133 citations · 23 references
PharmacyCell BiologyToxicologyBiochemical ToxicologyCellular PharmacologyMolecular ImagingCellular ToxicologyCytotoxicity AssessmentCytotoxicity EvaluationFluorescence MicroscopyLabel-free ImagingToxicology AssessmentCell Viability AssaysCytotoxicity AssaysDigital Holographic MicroscopyHigh-content Cytotoxicity ScreeningHigh-content ScreeningLabel-free AssaysLabel-free MicroscopyToxicity Screening Assays
We introduce a label-free technology based on digital holographic microscopy (DHM) with applicability for screening by imaging, and we demonstrate its capability for cytotoxicity assessment using mammalian living cells. For this first high content screening compatible application, we automatized a digital holographic microscope for image acquisition of cells using commercially available 96-well plates. Data generated through both label-free DHM imaging and fluorescence-based methods were in good agreement for cell viability identification and a Z'-factor close to 0.9 was determined, validating the robustness of DHM assay for phenotypic screening. Further, an excellent correlation was obtained between experimental cytotoxicity dose-response curves and known IC50 values for different toxic compounds. For comparable results, DHM has the major advantages of being label free and close to an order of magnitude faster than automated standard fluorescence microscopy.
23
Pierre Marquet, Benjamin Rappaz, Pierre J. Magistretti et al. · Optics Letters · 2005 · 1.2K citations · Full text
High-throughput RNAi screening by time-lapse imaging of live human cells
Beate Neumann, Michael Held, Urban Liebel et al. · Nature Methods · 2006 · 390 citations